Novel HA-based Formulations

About Imeik Technology Development

Imeik Technology Development is a leading player in China's medical aesthetics market, focusing on injectable hyaluronic acid (HA) fillers and other regenerative medical products. The company went public on the Shenzhen Stock Exchange's ChiNext board in 2020, achieving significant market capitalization. Its core strategy involves continuous R&D to expand its product portfolio and maintain its competitive edge in the domestic aesthetic medicine sector, while also exploring international expansion opportunities.

Therapeutic Areas